Quest Diagnostics Incorporated (NYSE: DGX) is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company has about 43,000 employees, serves approximately ½ of all physicians & hospitals in the U.S., & reported 2009 revenues of $7.5 billion.
Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories.
Patients may have specimens collected in any of the company’s approximately 2,000 patient service centers. On a typical workday, testing is performed for about 550,000 patients.
With its MedPlus subsidiary, Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions.
The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.
Specialties
Diagnostic testing information and services, Clinical testing, cancer diagnostics and anatomic pathology services, Gene-based and other esoteric testing, Healthcare information technology solutions
Quest Diagnostics Activity on LinkedIn
-
Quest Diagnostics has a new Project Manager LEAN Software
Sabbas Millet is now Project Manager LEAN Software
-
Quest Diagnostics has a new Medical Examiner/Phlebotomist
Daksha Patel is now Medical Examiner/Phlebotomist
-
Quest Diagnostics has a new Lab Assistant II
Jennifer Leveille is now Lab Assistant II
-
Quest Diagnostics has a new Executive Assistant
Holly McNickle is now Executive Assistant
-
-
-
Quest Diagnostics has a new Director - Scientific Affairs, Clinical Trials
Jesper Nymann-Andersen Ph.D. is now Director - Scientific Affairs, Clinical Trials
-
Quest Diagnostics has a new Pricing Analyst
Craig Schuda is now Pricing Analyst, was Program Account Manager at American Hotel Register
-
-
Quest Diagnostics added a new product: Blueprint for Wellness

